Our client is a PE-backed global leader in the development and manufacturing of active pharmaceutical ingredients, focused on specialist niches with expertise in highly regulated and complex chemistries. The company delivers a differentiated service offering to pharma and biotech customers for every stage in the drug development lifecycle.
The executive talent team retained ECA Partners for ECA’s experience working with critical interim executive leadership roles centered around exit planning and because of ECA’s reputation for identifying high-caliber CEOs. The interim CEO selected successfully led the company through an operational and structural divestiture effort to position the Health business unit for sale in the private equity community. This involved re-evaluating and implementing changes to the operational, strategic, and sales functions.
Beyond Consulting Podcast
Get access to our proprietary salary database, with data and insights across private equity, PE portfolio companies, corporate strategy, and more…
Get in touch to find your next hire.